1,566 Results

NICE in final guidance rejects Onivyde (nanoliposomal encapsulated irinotecan) in combination with chemotherapy as a cost effective treatment for metastatic pancreatic cancer.- Shire plc.

 Added 21 hours ago

-The National Institute for Health and Care Excellence (NICE) published final guidance rejecting Onivyde (nanoliposomal encapsulated irinotecan) from Shire plc, in...

EU approves Xeljanz (tofacitinib citrate) for rheumatoid arthritis- Pfizer

 Added 1 day ago

The European Commission (EC) has approved Xeljanz (tofacitinib citrate) 5 mg twice daily (BID) oral tablets, from Pfizer, in combination...

EU CHMP recommends Trumenba (Meningococcal Group B Vaccine) immunization of individuals 10 years and older to prevent invasive meningococcal disease . - Pfizer

 Added 3 days ago

Pfizer Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

FDA approves Symproic (naldemedine) to treat opioid-induced constipation.- Shionogi + Purdue Pharma

 Added 4 days ago

Shionogi Inc. and Purdue Pharma L.P. announced that the FDA approved Symproic (naldemedine) 0.2 mg tablets C-II as a once-daily...

EU Commission approves Amgevita (biosimilar adalimumab) for all indications of the originator drug.- Amgen.

 Added 4 days ago

Amgen has announced that the European Commission (EC) has granted marketing authorization for Amgevita (biosimilar adalimumab) in all available indications....

CHMP recommends approval of Keytruda (pembrolizumab), for relapsed or refractory classical Hodgkin lymphoma- Merck Inc

 Added 4 days ago

Merck Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

FDA grants accelerated approval for Bavencio (avelumab)to treat Merkel cell carcinoma .-Merck KgAA + Pfizer

 Added 4 days ago

Merck and Pfizer Inc. announced that the FDA has approved Bavencio (avelumab) Injection 20 mg/mL, for intravenous use, for the...

Data from ABSORB III study showed that Absorb Bioresorbable Vascular Stent was comparable in efficacy to the Xience metallic drug-eluting stent-Abbott

 Added 6 days ago

Abbott has announced that data from the ABSORB III U.S. pivotal trial showed that Absorb, Abbott's first-of-its-kind dissolving stent, had...

Successful Phase III trial of Ameluz (5-aminolevulinic acid) with photodynamic therapy to treat actinic keratosis.- Biofrontera AG

 Added 6 days ago

Biofrontera AG announced detailed results from its Phase III clinical trial evaluating the safety and efficacy of its topical prescription...

RLX 030 (serelaxin) fails to meet endpoints of reduction of cardiovascular death or worsening heart failure in RELAX-AHF-2.- Novartis

 Added 6 days ago

Novartis announced results from the global Phase III RELAX-AHF-2 study investigating the efficacy, safety and tolerability of RLX 030 (serelaxin)...